Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

JCI’s Conversations with Giants in Medicine: Elizabeth Blackburn and Viviane Tabar

While great strides have been made with regard to gender equity in biomedical academia, there remains a stubborn imbalance in representation in senior leadership roles. The graduate students from the Gerstner Sloan Kettering Graduate School have launched a series called The Roots of Change: Conversations about Women’s Empowerment to grapple with the issue of representation. They invited two giants in medicine to reflect on their lives in medicine: Viviane Tabar and Elizabeth Blackburn. Dr. Tabar is the chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center and leads a stem cell biology lab focusing on the development of human embryonic stem cell–derived dopaminergic neurons for the treatment of Parkinson’s disease, among other cell-based therapies for the repair of brain injuries. Dr. Blackburn is the former president of the Salk Institute for Biomedical Studies and, before that leadership position, had a long career on the faculty at the University of California, Berkeley, and UC San Francisco. She is best known for her scientific work on telomeres; she shared the 2009 Nobel Prize in Physiology or Medicine for the discovery of telomerase. The first hour of the Roots of Change conversation, with feminist icon and writer Gloria Steinem, is available on the Sloan Kettering website (https://www.mskcc.org/watch-conversations-about-women-s-empowerment).

Published June 1, 2022, by Ushma S. Neill

Conversations with Giants in Medicine

Related articles

A conversation with Elizabeth Blackburn and Viviane Tabar
Inés Fernández Maestre, Yanyang Chen, Brianna Naizir, Ushma S. Neill
Inés Fernández Maestre, Yanyang Chen, Brianna Naizir, Ushma S. Neill
View: Text | PDF
Conversations with Giants in Medicine

A conversation with Elizabeth Blackburn and Viviane Tabar

  • Text
  • PDF
Abstract

Authors

Inés Fernández Maestre, Yanyang Chen, Brianna Naizir, Ushma S. Neill

×
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts